Our studies suggest that active lowering of proinflammatory states, including lowered MCP-1, by OCFAs may contribute to their associations with lower adipokines and lower risks of type 2 diabetes, cardiovascular disease, pancreatic cancer, and mortality14,15,19,23,28. Here, CCL2 is linked to type 2 diabetes mellitus.